logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12544510 B1

PDFFull Text
Date of Patent:
Feb. 10, 2026

Filed:

Oct. 01, 2024

Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system

Applicant:

Insulet Corporation, Acton, MA (US);

Inventors:

Joon Bok Lee, Acton, MA (US);

Jason O'connor, Acton, MA (US);

Yibin Zheng, Hartland, WI (US);

Ashutosh Zade, San Diego, CA (US);

Assignee:

INSULET CORPORATION, Acton, MA (US);

Attorney:

GOODWIN PROCTER LLP

Primary Examiner:

Neal Sereboff

Int. Cl.
CPC ...
G16H 20/17 (2018.01); A61B 5/00 (2006.01); A61B 5/145 (2006.01); A61K 38/22 (2006.01); A61K 38/26 (2006.01); A61K 38/28 (2006.01); A61M 5/14 (2006.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); G16H 40/67 (2018.01);
U.S. Cl.
CPC ...
A61M 5/1723 (2013.01); A61B 5/14532 (2013.01); A61B 5/4839 (2013.01); A61B 5/4866 (2013.01); A61B 5/7282 (2013.01); A61K 38/22 (2013.01); A61K 38/26 (2013.01); A61K 38/28 (2013.01); A61M 5/1408 (2013.01); A61M 5/14248 (2013.01); G16H 20/17 (2018.01); G16H 40/67 (2018.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/8206 (2013.01); A61M 2230/201 (2013.01);
Abstract

Disclosed herein are systems and methods for the delivery of a co-formulation of insulin and a second drug, such as GLP-1, using an automated insulin delivery system. In a first embodiment, a dose of insulin is calculated by a medication delivery algorithm and a reduction factor is applied to account for the effect of second drug on the user's daily insulin requirement. In a second embodiment of the invention, a total amount of the second drug administered to the user during the past 24 hours is used to modify the correction factor and the insulin-to-carbohydrate ratio used by the medication delivery algorithm to cause a reduction in the insulin delivered to the user to account for the effect of the administration of the second drug portion of the co-formulation.

Find Patent Forward Citations

Lee, Joon. (2026). Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system (U.S. Patent No. 12544510). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12544510

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…